Tag Archives: trial

NIH ‘very concerned’ about serious side effect in AstraZeneca coronavirus vaccine trial

“The highest levels of NIH are very concerned,” said Dr. Avindra Nath, intramural clinical director and a leader of viral research at the National Institute for Neurological Disorders and Stroke, an NIH division. “Everyone’s hopes are on a vaccine, and if you have a major complication the whole thing could get derailed.” A great deal… Read More »

New drug prolongs ALS patient survival in trial

An experimental medication that was recently shown to slow the progression of the neurodegenerative disease amyotrophic lateral sclerosis (ALS) has now demonstrated the potential to also prolong patient survival. The findings come from a clinical trial conducted by investigators at the Sean M. Healey & AMG Center for ALS at Harvard-afilliated Massachusetts General Hospital (MGH)… Read More »

NIH ‘Very Concerned’ About Serious Side Effect in Coronavirus Vaccine Trial

The Food and Drug Administration is weighing whether to follow British regulators in resuming a coronavirus vaccine trial that was halted when a participant suffered spinal cord damage, even as the National Institutes of Health has launched an investigation of the case. “The highest levels of NIH are very concerned,” said Dr. Avindra Nath, intramural… Read More »

KU School of Medicine looking for participants in clinical trial for COVID-19 vaccine – KWCH

WICHITA, Kan. (KWCH) – The KU School of Medicine in Wichita is looking for participants in a clinical trial for a COVID-19 vaccine. To be eligible, you must be at least 18 years old. The trial starts in late August in Wichita. KU School of Medicine Center of Clinical Research Director Dr. Tiffany Schwasinger-Schmidt, one… Read More »

Moderna Coronavirus Vaccine Trial Shows Promising Early Results

The first coronavirus vaccine to be tested in people appears to be safe and able to stimulate an immune response against the infection, the manufacturer, Moderna, announced on Monday, offering a glint of hope to a world desperate for ways to stop the pandemic. The preliminary findings, in the first eight people who each received… Read More »

Sage’s oral depression therapy fails in late-stage trial; shares plunge

(Reuters) – Sage Therapeutics Inc said on Thursday its experimental drug failed to improve condition of patients with severe depression in a late-stage study, setting up the drugmaker to lose about $ 4 billion in valuation when the market opens. The hotly anticipated data was expected to allow the company to widen its reach in… Read More »